MedTrace Logo

Vapocoolant (Pain Ease) Use for Venipuncture

NCT01712776 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-29

Study results available
· View outcomes & findings →

Summary

To determine the efficacy and safety of vapocoolant spray (Pain Ease Medium Stream) in decreasing the pain of venipuncture ("blood draw")

Conditions

Interventions

DEVICE

Vapocoolant (Pain Ease)

Topical stream 4-10 seconds duration to skin.

DEVICE

Nature's Tears Sterile Water

Topical stream 4-10 seconds duration to skin

Sponsors & Collaborators

  • Gebauer Company

    collaborator NETWORK

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Sharon E. Mace, M.D. · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01712776 on ClinicalTrials.gov